You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
|
---|---|
Published in |
BMC Cancer, March 2021
|
DOI | 10.1186/s12885-021-08031-z |
Pubmed ID | |
Authors |
Q. P. Janssen, J. L. van Dam, B. A. Bonsing, H. Bos, K. P. Bosscha, P. P. L. O. Coene, C. H. J. van Eijck, I. H. J. T. de Hingh, T. M. Karsten, M. B. van der Kolk, G. A. Patijn, M. S. L. Liem, H. C. van Santvoort, O. J. L. Loosveld, J. de Vos-Geelen, B. M. Zonderhuis, M. Y. V. Homs, G. van Tienhoven, M. G. Besselink, J. W. Wilmink, B. Groot Koerkamp |
X Demographics
The data shown below were collected from the profiles of 42 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 9 | 21% |
Brazil | 3 | 7% |
Spain | 2 | 5% |
United Kingdom | 2 | 5% |
India | 2 | 5% |
France | 1 | 2% |
Paraguay | 1 | 2% |
Nicaragua | 1 | 2% |
Colombia | 1 | 2% |
Other | 5 | 12% |
Unknown | 15 | 36% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 18 | 43% |
Practitioners (doctors, other healthcare professionals) | 15 | 36% |
Scientists | 9 | 21% |
Mendeley readers
The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 109 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 18 | 17% |
Other | 9 | 8% |
Student > Ph. D. Student | 9 | 8% |
Student > Bachelor | 8 | 7% |
Student > Doctoral Student | 7 | 6% |
Other | 17 | 16% |
Unknown | 41 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 39 | 36% |
Biochemistry, Genetics and Molecular Biology | 6 | 6% |
Agricultural and Biological Sciences | 3 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Unspecified | 3 | 3% |
Other | 10 | 9% |
Unknown | 45 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 41. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 February 2022.
All research outputs
#1,032,571
of 25,802,847 outputs
Outputs from BMC Cancer
#131
of 9,104 outputs
Outputs of similar age
#28,720
of 456,680 outputs
Outputs of similar age from BMC Cancer
#3
of 267 outputs
Altmetric has tracked 25,802,847 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,104 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,680 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 267 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.